Lab M Gains ISO 17025 Accreditation from UKAS
News Nov 13, 2015
The quality control laboratory of Lab M’s facilities in Heywood, UK, has been granted ISO 17025:2005 accreditation by the United Kingdom Accreditation Service (UKAS).
Lab M’s schedule of accreditation covers both the physical and microbiological performance testing of the company’s ready-to-use Pinnacle™ media range. The five methods that were accredited include pH, sterility, fill volume, qualitative performance testing and quantitative performance testing. All methods are based on the new requirements of BS EN ISO 11133:14.
“The requirements of BS EN ISO 11133:14 have been considered throughout the expansion of our Pinnacle range. This newly published standard has been a major focus of all manufacturers and users of culture media,” said Lyn Richards, quality assurance and regulatory affairs manager at Lab M. “The implementation of the new requirements of the standard to all of our QC testing has been a major focus for Lab M over the last 12 months, and to have the methods accredited to ISO 17025 is the next step to demonstrate the quality of the testing of our products. This accreditation will also support the production quality of our ready-to-use media range.”
Lab M’s QC laboratory is a purpose-built facility that is staffed by an experienced team of microbiologists, some of whom have worked with Lab M for more than 20 years. The QC laboratory also has an ongoing investment programme with regards to equipment.
UKAS is the national accreditation body for the United Kingdom, appointed by government, to assess organizations that provide certification, testing, inspection and calibration services.
Accreditation determines the technical competence and integrity of organizations offering testing, inspection, calibration, verification and certification services.
In August, Lab M was acquired by Neogen Corporation, a world-wide leader in the development of food and animal safety products and services.
Horizon Enters into Partnership with Pirbright Institute to Improve Vaccine YieldsNews
Extends Horizon’s biomanufacturing capabilities into vaccine manufacture. Research supported by a grant from the Canadian International Development Research Centre, funded by the Bill and Melinda Gates foundation.READ MORE
Lonza Opens World’s Largest Dedicated Cell-and-Gene-Therapy Manufacturing Facility in TexasNews
First-of-its-kind, state-of-the-art manufacturing facility with capacity to produce treatment for thousands of patients suffering from rare genetic disorders or life-threatening diseases.READ MORE
IONTAS and IGEM Therapeutics Collaborate to Identify Novel IgE AntibodiesNews
The project will add to IGEM’s pipeline of drugs and expand upon IGEM-F, an IgE targeting ovarian and other cancers, currently in a Phase 1/2a study.READ MORE
Comments | 0 ADD COMMENT
15th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry
Sep 09 - Sep 12, 2018
CE in the Biotechnology & Pharmaceutical Industries: 20th Symposium on the Practical Applications for the Analysis of Proteins, Nucleotides & Small Molecules
Sep 09 - Sep 12, 2018